Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients. [electronic resource]
Producer: 20180727Description: 1666-1676 p. digitalISSN:- 1530-0285
- Adult
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Agents, Immunological -- therapeutic use
- B7 Antigens -- metabolism
- B7-H1 Antigen -- antagonists & inhibitors
- Biomarkers, Tumor -- metabolism
- Disease Progression
- Drug Resistance, Neoplasm -- physiology
- Female
- Humans
- Male
- Melanoma -- drug therapy
- Middle Aged
- Nivolumab
- Skin Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.